79 research outputs found
Quaternary TDM-PAM as upgrade path of access PON beyond 10Gb/s
A 20 Gb/s quaternary TDM-PAM passive optical network with chirped and non-linear optical transmitters is experimentally demonstrated. The migration from legacy TDM-PONs and the implications of using available 10 Gb/s components are analyzed. We show that a loss budget of 27.3 dB is compatible together with a packet power ratio of 10 dB between loud and soft optical network units. (c) 2012 Optical Society of Americ
Recommended from our members
In silico and in vitro analysis of lncRNA XIST reveals a panel of possible lung cancer regulators and a five-gene diagnostic signature
Ā© 2020 by the authors. Long non-coding RNAs (lncRNAs) perform a wide functional repertoire of roles in cell biology, ranging from RNA editing to gene regulation, as well as tumour genesis and tumour progression. The lncRNA X-inactive specific transcript (XIST) is involved in the aetiopathogenesis of non-small cell lung cancer (NSCLC). However, its role at the molecular level is not fully elucidated. The expression of XIST and co-regulated genes TSIX, hnRNPu, Bcl-2, and BRCA1 analyses in lung cancer (LC) and controls were performed in silico. Differentially expressed genes (DEGs) were determined using RNA-seq in H1975 and A549 NSCLC cell lines following siRNA for XIST. XIST exhibited sexual dimorphism, being up-regulated in females compared to males in both control and LC patient cohorts. RNA-seq revealed 944 and 751 DEGs for A549 and H1975 cell lines, respectively. These DEGs are involved in signal transduction, cell communication, energy pathways, and nucleic acid metabolism. XIST expression associated with TSIX, hnRNPu, Bcl-2, and BRCA1 provided a strong collective feature to discriminate between controls and LC, implying a diagnostic potential. There is a much more complex role for XIST in lung cancer. Further studies should concentrate on sex-specific changes and investigate the signalling pathways of the DEGs following silencing of this lncRNA
LogicWiSARD: Memoryless synthesis of weightless neural networks
Weightless neural networks (WNNs) are an alternative pattern recognition technique where RAM nodes function as neurons. As both training and inference require mostly table lookups, few additions, and no multiplications, WNNs are suitable for high-performance and low-power embedded applications. This work introduces a novel approach to implement WiSARD, the leading WNN state-of-the-art architecture, completely eliminating memories and arithmetic circuits and utilizing only logic functions. The approach creates compressed minimized implementations by converting trained WNN nodes from lookup tables to logic functions. The proposed LogicWiSARD is implemented in FPGA and ASIC technologies to illustrate its suitability for edge inference. Experimental results show more than 80% reduction in energy consumption when the proposed LogicWiSARD model is compared with a multilayer perceptron network (MLP) of equivalent accuracy. Compared to previous work on FPGA implementations for WNNs, convolutional neural networks, and binary neural networks, the energy savings of LogicWiSARD range between 32.2% and 99.6%.info:eu-repo/semantics/acceptedVersio
ULEEN: A Novel Architecture for Ultra Low-Energy Edge Neural Networks
The deployment of AI models on low-power, real-time edge devices requires
accelerators for which energy, latency, and area are all first-order concerns.
There are many approaches to enabling deep neural networks (DNNs) in this
domain, including pruning, quantization, compression, and binary neural
networks (BNNs), but with the emergence of the "extreme edge", there is now a
demand for even more efficient models. In order to meet the constraints of
ultra-low-energy devices, we propose ULEEN, a model architecture based on
weightless neural networks. Weightless neural networks (WNNs) are a class of
neural model which use table lookups, not arithmetic, to perform computation.
The elimination of energy-intensive arithmetic operations makes WNNs
theoretically well suited for edge inference; however, they have historically
suffered from poor accuracy and excessive memory usage. ULEEN incorporates
algorithmic improvements and a novel training strategy inspired by BNNs to make
significant strides in improving accuracy and reducing model size. We compare
FPGA and ASIC implementations of an inference accelerator for ULEEN against
edge-optimized DNN and BNN devices. On a Xilinx Zynq Z-7045 FPGA, we
demonstrate classification on the MNIST dataset at 14.3 million inferences per
second (13 million inferences/Joule) with 0.21 s latency and 96.2%
accuracy, while Xilinx FINN achieves 12.3 million inferences per second (1.69
million inferences/Joule) with 0.31 s latency and 95.83% accuracy. In a
45nm ASIC, we achieve 5.1 million inferences/Joule and 38.5 million
inferences/second at 98.46% accuracy, while a quantized Bit Fusion model
achieves 9230 inferences/Joule and 19,100 inferences/second at 99.35% accuracy.
In our search for ever more efficient edge devices, ULEEN shows that WNNs are
deserving of consideration.Comment: 14 pages, 14 figures Portions of this article draw heavily from
arXiv:2203.01479, most notably sections 5E and 5F.
Recommended from our members
COVIDā19 and SARSāCoVā2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease
Copyright: Ā© Katopodis et al. Severe acute respiratory syndrome (SARS) coronavirusā2 (SARSāCoVā2), the causative viral agent for the ongoing COVIDā19 pandemic, enters its host cells primarily via the binding of the SARSāCoVā2 spike (S) proteins to the angiotensināconverting enzyme 2 (ACE2). A number of other cell entry mediators have also been identified, including neuropilinā1 (NRP1) and transmembrane protease serine 2 (TMPRSS2). More recently, it has been demonstrated that transmembrane protease serine 4 (TMPRSS4) along with TMPRSS2 activate the SARSāCoVā2 S proteins, and enhance the viral infection of human small intestinal enterocytes. To date, a systematic analysis of TMPRSS4 in health and disease is lacking. In the present study, using in silico tools, the gene expression and genetic alteration of TMPRSS4 were analysed across numerous tumours and compared to controls. The observations were also expanded to the level of the central nervous system (CNS). The findings revealed that TMPRSS4 was overexpressed in 11 types of cancer, including lung adenocarcinoma, lung squamous cell carcinoma, cervical squamous cell carcinoma, thyroid carcinoma, ovarian cancer, cancer of the rectum, pancreatic cancer, colon and stomach adenocarcinoma, uterine carcinosarcoma and uterine corpus endometrial carcinoma, whilst it was significantly downregulated in kidney carcinomas, acute myeloid leukaemia, skin cutaneous melanoma and testicular germ cell tumours. Finally, a high TMPRSS4 expression was documented in the olfactory tubercle, paraolfactory gyrus and frontal operculum, all brain regions which are associated with the sense of smell and taste. Collectively, these data suggest that TMPRSS4 may play a role in COVIDā19 symptomatology as another SARSāCoVā2 host cell entry mediator responsible for the tropism of this coronavirus both in the periphery and the CNS
Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
Two recent North American studies have shown that completion of 5-fluorouracil (5FU)-based adjuvant chemotherapy is a major prognostic factor for the survival of elderly stage III colon cancer patients. The aim of the present study was to confirm this finding in a population-based series from Australia. The study cohort comprised 851 stage III colon cancer patients treated by surgery alone and 461 who initiated the Mayo chemotherapy regime. One-third of patients who initiated chemotherapy failed to complete more than three cycles of treatment. Independent predictors for failure to complete were treatment in district or rural hospitals, low socioeconomic index and treatment by a low-volume surgeon. Patients who failed to complete chemotherapy showed worse cancer-specific survival compared not only to those who completed treatment (HR=2.24; 95% confidence interval (CI) (1.66ā3.03), P<0.001) but also to those treated by surgery alone (HR=1.37; 95% CI (1.09ā1.72), P=0.008). The current and previous studies demonstrate the importance of completing adjuvant 5-FU-based chemotherapy for colon cancer. Further prospective studies are required to identify better the physiological and socioeconomic factors responsible for failure to complete chemotherapy so that appropriate improvements in health service delivery can be made
Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece
<p>Abstract</p> <p>Introduction</p> <p>In Greece, fusidic acid and clindamycin are commonly used for the empiric therapy of suspected staphylococcal infections.</p> <p>Methods</p> <p>The medical records of children examined at the outpatient clinics or admitted to the pediatric wards of the University General Hospital of Larissa, Central Greece, with community-associated staphylococcal infections from January 2003 to December 2009 were reviewed.</p> <p>Results</p> <p>Of 309 children (0-14 years old), 21 (6.8%) had invasive infections and 288 (93.2%) skin and soft tissue infections (SSTIs). Thirty-five patients were ā¤30 days of age. The proportion of staphylococcal infections caused by a community-associated methicillin-resistant <it>Staphylococcus aureus </it>(CA-MRSA) isolate increased from 51.5% (69 of 134) in 2003-2006 to 63.4% (111 of 175) in 2007-2009 (<it>P </it>= 0.037). Among the CA-MRSA isolates, 88.9% were resistant to fusidic acid, 77.6% to tetracycline, and 21.1% to clindamycin. Clindamycin resistance increased from 0% (2003) to 31.2% (2009) among the CA-MRSA isolates (<it>P </it>= 0.011). Over the 7-year period, an increase in multidrug-resistant CA-MRSA isolates was observed (<it>P </it>= 0.004). One hundred and thirty-one (93.6%) of the 140 tested MRSA isolates were Panton-Valentine leukocidin-positive. Multilocus sequence typing of 72 CA-MRSA isolates revealed that they belonged to ST80 (n = 61), ST30 (n = 6), ST377 (n = 3), ST22 (n = 1), and ST152 (n = 1). Resistance to fusidic acid was observed in ST80 (58/61), ST30 (1/6), and ST22 (1/1) isolates.</p> <p>Conclusion</p> <p>In areas with high rate of infections caused by multidrug-resistant CA-MRSA isolates, predominantly belonging to the European ST80 clone, fusidic acid and clindamycin should be used cautiously as empiric therapy in patients with suspected severe staphylococcal infections.</p
Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy
Description and performance of track and primary-vertex reconstruction with the CMS tracker
A description is provided of the software algorithms developed for the CMS tracker both for reconstructing charged-particle trajectories in proton-proton interactions and for using the resulting tracks to estimate the positions of the LHC luminous region and individual primary-interaction vertices. Despite the very hostile environment at the LHC, the performance obtained with these algorithms is found to be excellent. For tbar t events under typical 2011 pileup conditions, the average track-reconstruction efficiency for promptly-produced charged particles with transverse momenta of pT > 0.9GeV is 94% for pseudorapidities of |Ī·| < 0.9 and 85% for 0.9 < |Ī·| < 2.5. The inefficiency is caused mainly by hadrons that undergo nuclear interactions in the tracker material. For isolated muons, the corresponding efficiencies are essentially 100%. For isolated muons of pT = 100GeV emitted at |Ī·| < 1.4, the resolutions are approximately 2.8% in pT, and respectively, 10Ī¼m and 30Ī¼m in the transverse and longitudinal impact parameters. The position resolution achieved for reconstructed primary vertices that correspond to interesting pp collisions is 10ā12Ī¼m in each of the three spatial dimensions. The tracking and vertexing software is fast and flexible, and easily adaptable to other functions, such as fast tracking for the trigger, or dedicated tracking for electrons that takes into account bremsstrahlung
Alignment of the CMS tracker with LHC and cosmic ray data
Ā© CERN 2014 for the benefit of the CMS collaboration, published under the terms of the Creative Commons Attribution 3.0 License by IOP Publishing Ltd and Sissa Medialab srl. Any further distribution of this work must maintain attribution to the author(s) and the published article's title, journal citation and DOI.The central component of the CMS detector is the largest silicon tracker ever built. The precise alignment of this complex device is a formidable challenge, and only achievable with a significant extension of the technologies routinely used for tracking detectors in the past. This article describes the full-scale alignment procedure as it is used during LHC operations. Among the specific features of the method are the simultaneous determination of up to 200 000 alignment parameters with tracks, the measurement of individual sensor curvature parameters, the control of systematic misalignment effects, and the implementation of the whole procedure in a multi-processor environment for high execution speed. Overall, the achieved statistical accuracy on the module alignment is found to be significantly better than 10Ī¼m
- ā¦